{
  "id": 11210310,
  "title": "HIV prevention drug hailed as breakthrough, but who gets access?",
  "url": "https://urgent.news/2026/10/01/hiv-prevention-drug-hailed-as-breakthrough-but-who-gets-access",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-01T13:54:50.000Z",
  "source": {
    "name": "Al Jazeera",
    "slug": "al-jazeera",
    "url": "https://www.aljazeera.com/news/2026/10/1/hiv-prevention-drug-hailed-as-breakthrough-but-who-gets-access?traffic_source=rss"
  },
  "original_language": "en",
  "account": null,
  "summary": "Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}